IP – a vital framework to create healthier living Every year in April, the global community celebrates World Intellectual Property Day. At Fertin, we recognize the importance of putting Intellectual Property (IP) in the limelight. We believe that IP is a vital framework and powerful tool to advance new ideas and to stimulate cutting-edge research

NordicCan, a full Contract Development and Manufacturing Organisation specialized in innovative cannabinoid solutions for the B2B market, announced that the Canadian Intellectual Property Office has issued patent numbers CA 3,031,530 and CA 3,035,400 covering the use of cannabinoids within NordicCan’s extruded and compressed chewing gum formulations, including its unique bi-layered compressed gum format. “These patents

It has been more than one year since the COVID-19 pandemic hit the world and changed nearly every aspect of our existence. We are adjusting to a new reality in most parts of our lives, as businesses as well as individuals. Although there is still undoubtedly uncertainty in the days ahead, we would like to

VEJLE, Denmark—March 7, 2021—NordicCan, a full Contract Development and Manufacturing Organisation specialized in innovative cannabinoid solutions for the B2B market, has obtained approval a Research License from Health Canada under the Cannabis Act. The Research License is a key element in NordicCan’s strategy of obtaining the processing license for cannabinoid oral dosage formats from the

VEJLE, Denmark—March 5, 2021—NordicCan, a full Contract Development and Manufacturing Organisation specialized in innovative cannabinoid solutions for the B2B market, today announced that the United States Patent and Trademark Office (USPTO) has issued it two patents: U.S. Patent No. 10,925,853 and US 10,933,017 cover the use of cannabinoids within NordicCan’s oral dosage formats Zapliq Chewable

During the 2021 edition of PLMA online trade show to be held on February 3 and 4, 2021, Fertin Pharma will present its ready-to-license caffeine chewing gum. Together with its subsidiary Tab Labs, Fertin Pharma will present this innovative product, which is a quick and convenient delivery system for that all-important caffeine-induced pick-me-up at the

Full Contract Development and Manufacturing Organization will continue to specialize in innovative cannabinoid solutions for the B2B market MedCan Pharma A/S announced today the launch of a new corporate name and brand identity. The organization will now be known as NordicCan A/S. The new name is reflected in a new logo, domain name, www.nordiccan.com and